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Abstract
Background: We aimed to evaluate the prevalence of hip and knee osteoarthritis (HOA and KOA) according to
American College of Rheumatology (ACR) criteria among participants with suspected early symptomatic osteoarthritis
(OA) in the CHECK cohort. We also assessed whether participants not fulfilling ACR criteria at baseline develop ACR-
defined OA at 2-year and/or 5-year follow up, and which baseline factors are associated with this development.
Methods: The CHECK cohort included 1002 subjects with first presentation of knee and/or hip complaints. The primary
outcome was onset of HOA and/or KOA according to the ACR criteria, including the clinical classification criteria and
the combined clinical and radiographic classification criteria at 2-year and/or 5-year follow up.
Results: Of the participants with hip complaints, 63% (n = 370) were classified as having HOA at baseline according to
the ACR criteria. Of those not classified with HOA at baseline, 40% developed HOA according to the clinical or
combined clinical/radiographic ACR criteria after 2 and/or 5 years. Up to 92% of participants (n = 829) with knee
complaints were classified as having KOA at baseline; of those not classified with KOA at baseline, 55% developed KOA
according to the clinical ACR criteria or the clinical/radiographic ACR criteria after 2 and/or 5 years. The following
factors were associated with development of HOA: morning stiffness (OR 2.39; 95% CI 1.14–4.98), painful internal
rotation (OR 2.53; 95% CI 1.23–5.19), hip flexion < 115° (OR 2.33; 95% CI 1.17–4.64) and erythrocyte sedimentation rate
(ESR) < 20mm/h (OR 2.94; 95% CI 1.13–7.61). No variables were associated with development of KOA at 2-year and/or
5-year follow up.
Conclusions: A large proportion of persons with hip complaints not fulfilling the ACR criteria at baseline develop HOA
after 2 and/or 5 years of follow up. Almost all persons with knee complaints already fulfill the clinical and/or
radiographic ACR criteria for OA, and half of the persons not fulfilling criteria at baseline will do so after 5 years of follow
up. Several individual ACR criteria for HOA at baseline were associated with the development of HOA at follow up. This
association was not proven for KOA, probably because of the small number of subjects developing KOA in this study.
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Introduction
Osteoarthritis (OA) is associated with joint pain and
functional limitation and is a leading cause of disability
among older people. OA is considered the most com-
mon form of arthritis from which 15–18% of the popula-
tion suffers [1]. Approximately 22% of the general
population suffers from knee pain, and knee and hip
pain are even more common in older people [2, 3]. This
generally leads to consultation with a physician: e.g., 33%
of the population with knee pain in the UK consults a
general practitioner (GP) in primary care [4]. One rea-
son for consultation is that patients with knee pain are
looking for a definite diagnosis [5]. However, no clear
clinical diagnostic primary care tools are available. Diag-
nosis of OA is often based on radiological evidence and/
or on recommendations formulated by OA experts ac-
tive in secondary care [6].
The diagnosis of OA in patients suffering from knee
or hip pain in primary care would become easier if
well-defined criteria were used. The American College
of Rheumatology (ACR) has developed different criteria
for the classification of OA of the knee and hip in order
to promote uniformity in reporting OA in epidemio-
logical and intervention studies. These criteria were de-
veloped using combinations of clinical, clinical/
laboratory, and clinical, laboratory and radiographic cri-
teria [7, 8]. Although these criteria were developed pri-
marily for epidemiological purposes rather than for
clinical use, the ACR criteria are commonly used as a
diagnostic tool in secondary care. Because the criteria
were developed in secondary care with patients with
(mostly) rheumatoid arthritis (RA) in the control group,
these criteria might primarily distinguish patients with
OA from patients with RA. Furthermore, it has been
suggested that the criteria are probably mainly diagnos-
tic for late-stage OA [9]. More uniform and early diag-
nosis of OA would provide a better window of
opportunity for interventions and a clear diagnosis could
also help to motivate patients for often-difficult lifestyle
changes involved with such a diagnosis.
The present study aimed to evaluate the prevalence of
ACR criteria in subjects with knee and hip complaints and
whether they will develop evident OA according to the
ACR criteria for hip and knee OA. This study also aimed
to determine predictive factors for the development of
knee/hip OA according to the ACR criteria, during 5-year
follow up. These predictive factors may help to diagnose
OA at an earlier stage in primary care and thereby pro-
mote earlier treatment according to established guidelines.
Patients and methods
Study design
The CHECK (cohort hip and cohort knee) study is a
prospective cohort study of 1002 individuals who first
presented with knee and/or hip pain. Details of the
protocol are published elsewhere and a summary is pre-
sented below [10]. No ethical approval is required for a
prognostic cohort without interventions in the
Netherlands.
Study population
Patients that potentially fulfilled the inclusion criteria
were invited to join the study when they visited their
GP. In addition, participants were recruited through ad-
vertisements, articles in local newspapers, and via the
website of the Dutch Arthritis Association. Individuals
were eligible to participate if they had pain and/or stiff-
ness of the knee and/or hip, were aged between 45 and
65 years, and had not yet consulted their physician for
these symptoms, or the first consultation was within the
preceding 6 months.
First presenters with pathological, previously diagnosed,
conditions that obviously explained the existing symptoms
(e.g. other rheumatic disease, isolated tendinitis/bursitis,
previous hip or knee joint replacement, congenital dyspla-
sia, osteochondritis dissecans, intra-articular fractures,
septic arthritis, Perthes’ disease, ligament or meniscus
damage, plica syndrome or Bakers’ cysts (sign of more ad-
vanced OA)) were excluded. Other exclusion criteria were
co-morbidity that precluded physical evaluation and/or
follow up for at least 10 years, malignancy in the last 5
years, and inability to understand the Dutch language [10].
Physicians at the participating centers checked
whether referred patients and patients from their out-
patient clinic, fulfilled the inclusion criteria. All patients
underwent radiographic assessment and a physical
examination, and filled out an extensive questionnaire at
baseline, and at 2-year and 5-year follow up.
Outcome measures
OA of the hip/knee was determined using the ACR cri-
teria for hip and knee OA [7, 8]. We determined the
clinical classification criteria, and the combined clinical
and radiographic classification criteria. The clinical clas-
sification of OA of the hip was determined using hip
flexion measured during physical examination instead of
the erythrocyte sedimentation rate (ESR), as ESR was
only available at baseline. Therefore, we followed the al-
ternative proposed by the ACR when the ESR is not
available; these alternative criteria were reported to be
equally sensitive and specific [8].
For the classification of knee OA, the clinical criteria
and the combined clinical and radiographic criteria were
determined. The criteria were first defined per joint (i.e.
left and right hip/knee) separately. A participant was
classified as having hip or knee OA when at least one of
the two joints fulfilled one of the ACR criteria at 2-year
and/or at 5-year follow up for the hip and the knee
Damen et al. Arthritis Research & Therapy            (2019) 21:4 Page 2 of 7
separately, e.g. patients fulfilling ACR criteria at 2 years
and not at 5 years of follow up would be classified as pa-
tients with OA.
Predictors
The predictors assessed were factors available at consult-
ation with the GP, and consisted of demographic factors
(age, gender and body mass index (BMI)), anamnestic fac-
tors (site of pain, pain score in the last week and morning
stiffness), co-morbidity (lower back pain, previous surgery
in the knee or hip, use of analgesics, unilateral or bilateral
hip or knee pain), factors from physical examination (pain
ont hip/knee flexion, pain and reduced range of motion
(ROM) on internal rotation (ROM < 15 vs. > = 15°) and
hip flexion (ROM > 115 vs. < =115°), presence of
Heberden’s nodules, palpable warmth of the knee, patello-
femoral grinding, joint line tenderness, bony enlargement
of the knee) and simple diagnostic tests such as Kellgren
and Lawrence grade (K&L 0 vs. ≥ 1) on conventional radi-
ography and ESR (< 20mm/h). An overview of all tested
variables (19 in the hip cohort and 21 in the knee cohort)
is presented in Additional file 1: Table S1.
Data analysis
To reduce bias and improve efficiency, we performed
multiple imputation of missing values at baseline. We
generated 10 imputed datasets using chained equations
implemented in the R routine MICE. All analyses were
done separately on the 10 imputation sets. A weighted
mean outcome (as proposed by Rubin) was calculated
[11]. Separate logistic regression models were con-
structed for participants with hip or knee complaints at
baseline, but who were not classified at baseline as hav-
ing OA according to the ACR classification criteria for
hip and knee OA. Predictors used are described in
Additional file 1: Table S1. Because of the large number
of measured predictors a data reduction method was
used. Predictors related to the outcome (p < 0.2) were
divided into five categories (i.e. demographics, com-
plaints and symptoms, co-morbidities, physical examin-
ation, and diagnostic interventions). Per category of
participants with knee or hip complaints a multiple lo-
gistic or linear regression (enter method) analysis was
performed with predictors that were univariately associ-
ated with the outcome (p < 0.2). All predictors selected
in the different categories were again entered into the
final logistic or linear regression analysis to build the
final model (p < 0.05). The results are presented as odds
ratios (OR) with 95% confidence intervals (CI). Predict-
ive values and likelihood ratios were calculated [12]. All
analyses were performed with the SPSS software pack-
age (version 22.0.0.0).
Results
The baseline characteristics of the study population are
presented in Table 1. Of the 1002 participants in the
CHECK cohort, 79.0% was female and mean age was







Women, % 79.0 79.6 80.8
Age in years (SD) 55.9 (5.2) 56.0 (5.1) 55.8 (5.3)
BMI (SD) 26.2 (4.1) 26.4 (4.1) 26.1 (4.1)
WOMAC pain (SD) 25.4 (17.2) 25.6 (17.3) 27.2 (17.1)
WOMAC function 23.5 (17.1) 24 (17.3) 25.3 (17.6)
WOMAC stiffness 33.2 (21.1) 33.8 (21.1) 34.8 (21.2)
NRS (0–10) (SD) 3.6 (2.1) 3.6 (2.1) 3.7 (2.1)
Hip pain, % 58.7 50.1 100.0
Knee pain, % 83.0 100.0 71.1
ACR clinical knee OA, (%) 674 (81.3)
ACR combined knee OA (%) 606 (73.1)
Clinical/combined knee OA (%) 760 (91.7)
ACR clinical hip OA (%) 162 (27.6)
ACR combined hip OA (%) 322 (54.7)
Clinical or combined hip OA (%) 370 (62.9)
SD standard deviation, NRS numeric rating scale (0–10), BMI body mass index, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index scores (0–100),
ACR American College of Rheumatology, OA osteoarthritis
aParticipant with either knee, or knee and hip pain
bParticipant with either hip, or hip and knee pain
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55.9 years. Of the total study population, 58.7% (n = 588)
had hip complaints, either stiffness or pain, at baseline.
Of these, 27.6% (n = 162) were classified as having hip
OA at baseline according to the ACR clinical criteria,
50.0% (n = 295) according to the combined clinical/
radiographic criteria for hip OA, and 62.9% (n = 370)
met either one or the other of these criteria. Knee
complaints were reported at baseline by 82.7% of pa-
tients (n = 829), of whom, 81.3% (n = 674) were classified
as having knee OA at baseline according to the ACR
clinical criteria,73.1% (n = 606) according to the
combined clinical/radiographic criteria for knee OA,
and 91.7% (n = 760) met either one or the other of
these criteria.
Predictive factors in participants with hip complaints and
development of OA according to the ACR criteria
Of the 198 participants with hip complaints that were
not classified as having hip OA at baseline according to
the ACR clinical and/or combined criteria and were not
lost to follow up, 80 fulfilled the ACR criteria at 2-year
and/or 5-year follow up. Based on the 19 potential pre-
dictive factors measured at baseline, 8 univariately sig-
nificant factors were included in the final multivariate
logistic regression model. This model identified the fol-
lowing baseline factors: morning stiffness (OR 2.39; 95%
CI 1.14–4.98, positive likelihood ratio (LR+) 1.56), pain-
ful internal rotation (OR 2.53; 95% CI 1.23–5.19, LR+
1.71), hip flexion < 115° (OR 2.33 95% CI 1.17–4.64, LR
+ 1.47) and ESR < 20mm/h (OR 2.94; 95% CI 1.13–7.61,
LR+ 0.77) (Table 2).
Combinations of these factors provided even higher
likelihood ratios. Individuals with both morning stiffness
and painful internal rotation had a LR+ of 4.03 (positive
predictive value (PPV) 0.73, negative predictive value
(NPV) 0.64, negative likelihood ratio (LR-) 0.83). When
individuals presented with morning stiffness, painful in-
ternal rotation and hip flexion < 115°, the LR+ was 15
(PPV 0.91, NPV 0.63, LR- 0.88). Addition of ESR < 20
mm/h as a predictor did not enhance the predictive
value (LR+ 12,66, LR- 0.89, PPV 0.9, NPV 0.61).
Predictive factors in participants with knee complaints
A total of 64 participants with knee pain were not classi-
fied as having knee OA at baseline according to the ACR
clinical and/or combined criteria and were not lost to fol-
low up. Of these, 35 fulfilled the ACR criteria at 2-year
and/or 5-year follow up. In this group, 21 potential pre-
dictive factors were measured at baseline (Additional file 1:
Table S1). Age, morning stiffness, joint line tenderness
and ESR < 20mm/h were included in the final multivariate
logistic regression model. In this small sample no variable
was statistically significant. Morning stiffness in the knee
lasting < 30min had a positive likelihood ratio (LR+) of
4.97 (PPV 0.86, NPV 0.49, LR- 0.08) (Table 3).
Discussion
This study demonstrates that the majority of patients
presenting for the first time with hip pain fulfill the
combined ACR hip OA criteria, both clinical or com-
bined ACR criteria, and that 40% of patients not fulfill-
ing those ACR criteria will develop evident OA
according to the clinical or combined ACR criteria for
Table 2 Multivariate regression analysis for hip OA at 2-years and/or 5-year follow up according to the ACR classification
criteria (n = 198, 80 cases, a priori risk = 0.40)
Baseline characteristics Analysis per category OR (95% CI) Multivariate analysis OR(95% CI) PPV NPV LR+ LR-
Demographics
Age (<= 50vs. > 50 years) 0.53(0.28–1.01) 0.90(0.41–1.99) 0.36 0.48 0.84 1.6
Complaints and symptoms
Pain last week, NRS 1.15(0.99–1.33) 1.04(0.87–1.26) na na na na
Morning stiffness hip (yes = 1/no = 0) 2.60 (1.14–3.71) 2.39 (1.14–4.98) 0.51 0.66 1.56 0.75
Comorbidities and interventions
Knee pain (yes = 1/no = 0) 0.63 (0.33–1.20) 0.71 (0.32–1.55) 0.37 0.51 0.89 1.42
Painkillers (yes = 1/no = 0) 2.01 (1.12–3.59) 1.60 (0.75–3.41) 0.5 0.67 1.47 0.73
Physical examination
Painful hip internal rotation (yes = 1/no = 0) 2.59 (1.43–4.67) 2.53 (1.23–5.19) 0.53 0.69 1.71 0.66
Hip flexion ROM (0 = > 115° vs. 1 = <= 115°) 2.00 (1.12–3.67) 2.33 (1.17–4.64) 0.5 0.67 1.47 0.73
Diagnostic tests
ESR < 20 mm/h 3.54 (1.30–7.13) 2.94 (1.13–7.61) 0.46 0.77 1.22 0.4
Bold values indicate significant values (p < 0.05) in the final model
ACR American College of Rheumatology, OR odds ratio, PPV positive predictive value, NPV negative predictive value, NRS numeric rating scale, ROM range of
motion, LR+ positive likelihood ratio, LR- negative likelihood ratio, na not applicable (continuous variable), ESR erythrocyte sedimentation rate
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the hip after 5 years. For this last subgroup we identified
the following predictive factors: morning stiffness, pain-
ful internal rotation, hip flexion < 115° and an ESR < 20
mm/h. Combinations of these signs and symptoms have
an even higher predictive value. In first presenters with
knee pain, up to 92% do fulfill the clinical or combined
ACR criteria, at baseline. For this reason, the number of
participants with knee symptoms not fulfilling the ACR
criteria was, in fact, too small to assess predictors of OA
development. This study is unique in having such a large
group of first presenters. We would like to argue that
the CHECK cohort represents people in (Dutch) primary
care presenting for the first time with hip and knee com-
plaints and suspected of having early OA.
We were surprised by the large percentage of partici-
pants fulfilling ACR criteria at baseline in participants
with hip complaints, and that this was even more pro-
nounced in participants with knee complaints. In a pre-
vious open population-based knee pain cohort that
included persons with chronic knee pain, 47% were not
diagnosed with OA at baseline [13]. This proportion is
larger than our proportion of participants without OA at
baseline. This difference could be due to the younger
age (mean age 45 years) and lower BMI in that cohort.
In that same study, the majority (86%) of persons devel-
oped OA during the 12-year follow up [13]. In our study,
a smaller proportion of participants with pain in the hip
(40%) and knee (55%) were diagnosed with either hip or
knee OA according to the ACR criteria during follow
up. However, this result could be related to the shorter
follow-up period in our study.
The predictive factors we identified to be associated
with the development of hip OA are consistent with the
previous literature. Morning stiffness and limited in-
ternal rotation are known predictors for total hip re-
placement in primary care [14, 15]. Age and pain levels,
however, were not statistically significant in the final
model in the current study whereas other studies found
these to be predictive [14, 15]. This could be explained
by our relatively young cohort with generally quite low
pain levels (Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) pain score 27.2 on a
scale of 0–100, numeric rating scale (NRS) 3.7, Table 1)
such as can be expected in a cohort with early OA. Lim-
ited hip flexion and ESR < 20 mm/h were not identified
previously as risk factors for the development of HOA
but were statistically significant in our final model. A
possible explanation could be that higher ESR was re-
lated to inflammatory diseases at baseline that were not
evident at the time of inclusion.
In contrast to previous studies we were unable to
identify predictors of the knee pain that develops into
knee OA [16, 17], even when we performed a separate
analysis for the clinical and the combined ACR criteria.
Also, in these subgroup analyses, no variables were sig-
nificantly associated with development of knee OA, ex-
cept for borderline significant results for morning
stiffness. The large percentage of patients with knee pain
who fulfill the ACR criteria at baseline is probably the
main reason for not finding significant predictive factors
based on OR. However the predictive values show that
morning stiffness would probably have had good prog-
nostic value if we had had greater statistical power.
As expected, the criteria associated with fulfilling the
ACR criteria at follow up, in either the combined or sep-
arate analysis for the clinical and the combined ACR cri-
teria, were all sub-items of the ACR criteria. This
indicates that pain in combination with one or more of
these sub-items of the ACR criteria might be indicative
of future OA.
There are currently no clear diagnostic criteria for OA
in primary care, e.g. the ACR criteria are widely used in
epidemiologic research but not validated in primary care.
Most discussions focus on the use of radiographic out-
comes [18]. For example, Kellgren and Lawrence (K&L)
grade ≥ 2 is accepted as a cutoff for OA in
Table 3 Multivariate regression analysis for knee OA at 2-year and/or 5-year follow up according to the ACR classification
criteria (n = 64, 35 cases, a priori risk = 0.55)
Baseline characteristics Analysis per category OR (95% CI) Multivariate analysis OR (95% CI) PPV NPV LR+ LR-
Demographics
Age (<=50 vs. > 50 years) 0.37 (0.13–1.36) 0.42 (0.14–1.06) 0.39 0.37 0.53 1.44
Complaints and symptoms
Morning stiffness knee (yes = 1/no = 0) 6.79 (0.65–51.23) 6.08 (0.53–69.93) 0.86 0.49 4.97 0.08
Physical examination
Joint line tenderness 1.05 (0.21–5.14) 1.92 (0.34–10.79) 0.73 0.5 2.2 0.8
Diagnostic tests
ESR < 20 mm/h 0.94 (0.87–1.02) 0.94 (0.85–1.03) na na na na
OR odds ratio, PPV positive predictive value, NPV negative predictive value, NRS numeric rating scale, ESR erythrocyte sedimentation rate, LR+ positive likelihood
ratio, LR- negative likelihood ratio, na not applicable (continuous variable)
p < 0.05
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epidemiological studies and (possibly) in secondary care.
The cutoff of K&L grade ≥ 1 is useful in epidemiologic
studies to predict progression, but its use is not advised in
primary care because knee radiography has no additional
value in the assessment of individual patients with knee
pain [19–22]. However, in the present study we chose to
examine not only clinical features but also radiographic
features, because of the availability and still frequent use
of radiography in primary care. Our study clearly showed
that radiographic features do not predict fulfillment of
ACR criteria, nor when assessed in subgroups of clinical
or combined ACR criteria (data not shown.)
The prevalence, incidence, and predictors of the inci-
dence of OA are clinically important findings, because
they implicate that most persons aged 45–65 years of
age presenting to a GP with no other hip or knee disease
could be diagnosed with clinical OA at that time or are
prone to developing clinical OA within the following
years. This could help to provide a clear diagnosis, which
contributes to early treatment according to the guide-
lines that are available for both hip and knee, whereas
undiagnosed knee and/or hip pain is usually treated ac-
cording to the best insight of the individual physician
[23–25]. For patients diagnosed with OA, first-step
treatments (e.g. education, lifestyle advice, and acet-
aminophen) should be started, due to their beneficial ef-
fects in the early stage of the disease process [26].
Our study offers a unique population to study hip and
knee pain in first presenters, because the patients included
are comparable with patients who would present to a pri-
mary care physician and therefore this study helps in ad-
dressing the diagnostic challenge of hip and knee pain in
primary care. A limitation of our study is that a substantial
number of variables were tested in the analysis. Due to the
limited number of OA cases identified, we could justify
testing only 2–5 variables per analysis per category when
building the explorative models. However, clinically rele-
vant variables were used (defined prior to our analyses)
that were previously applied in epidemiological/clinical re-
search and no new predictors were introduced. Further,
data reduction methods were used by means of restric-
tions based on p values by pre-analyzing the predictors in
their categories. Other predictors of OA could remain un-
exposed due to this lack of power.
Conclusion
The majority of people presenting with hip pain for the
first time fulfill the clinical or combined ACR criteria
and 40% of the patients not fulfilling those ACR criteria
will develop OA according to the clinical or combined
ACR criteria for the hip after 5 years. Predictive factors
for the development of HOA are morning stiffness, pain-
ful internal rotation, hip flexion < 115° and an ESR < 20
mm/h. In first presenters with knee pain, up to 92%
already fulfill the clinical or combined ACR criteria. No
predictive characteristics were identified for the develop-
ment of knee OA in those not fulfilling ACR criteria.
Recommendations
We would suggest that future studies validate whether
patients with hip complaints aged > 45 years with the
characteristics of morning stiffness, painful internal rota-
tion, hip flexion < 115° and an ESR < 20mm/h indeed
have early OA. It also needs to be validated whether first
presenters with knee complaints aged > 45 years indeed
have early KOA.
Additional file
Additional file 1: Table S1. All univarately tested variables in the hip
and knee cohort. (DOCX 23 kb)
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